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Abstract
Health related quality of life (HRQoL) has become an increasingly important indicator of
health status in clinical trials and epidemiological research. Moreover, the study of the rela-
tionship of HRQoL with patients’ and disease’s characteristics has become one of the primary
aims of many HRQoL studies. HRQoL scores are usually assumed to be distributed as binomial
random variables and often highly skewed. The use of the beta-binomial distribution in the
regression context has been proposed to model such data, however, the beta-binomial regression
has been performed by means of two different approaches in the literature: i) beta-binomial
distribution with a logistic link; and ii) hierarchical generalized linear models (HGLMs). None
of the existing literature in the analysis of HRQoL survey data has performed a comparison of
both approaches in terms of adequacy and regression parameter interpretation context.
This paper is motivated by the analysis of a real data application of HRQoL outcomes in pa-
tients with Chronic Obstructive Pulmonary Disease (COPD), where the use of both approaches
yields to contradictory results in terms of covariate effects significance and consequently the
interpretation of the most relevant factors in HRQoL. We present an explanation of the results
in both methodologies through a simulation study and address the need to apply the proper
approach in the analysis of HRQoL survey data for practitioners, providing an R package.
Keywords: Beta-binomial regression, Hierarchical GLM, Health Related Quality of Life,
Chronic Obstructive Pulmonary Disease, HRQoL R package.
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1 Introduction
It has previously stated that clinical and laboratory outcomes are not necessarily the most im-
portant outcome results in studies that examine the effect of health interventions (Testa and
Simonson, 1996). Moreover, patient-reported outcomes are increasingly used as primary out-
come measures in observational and experimental studies. For instance, health related quality
of life (HRQoL) has become an important outcome as a measure of health status and a way to
evaluate medical care results, especially in chronic diseases. The measurement of the HRQoL
provides information about the disease and its impact in the patient in a standardized, compara-
ble and objective way (Goldsmith, 1972). Measuring HRQoL can help determine the burden of
preventable disease, injuries, and disabilities, and it can provide valuable new insights into the
relationships between HRQoL and risk factors. Therefore, to study the relationship of HRQoL
with patients’ and disease’s characteristics has become one of the primary aims of many HRQoL
studies.
Several instruments for measuring HRQoL have been developed in form of questionnaires,
some of them in a generic way and other for specific diseases. One of the most widely used
generic instruments is the Short Form-36 (SF-36) Health Survey. The SF-36 has 36 items that
are reduced to 8 health dimensions, it was developed and validated and it has been translated
and validated into many languagesWare et al. (1993).
The beta-binomial distribution has been proposed in the literature to fit HRQoL data pro-
vided by the SF-36. In this context, a regression model based on the beta-binomial distribution
has been shown to be a good option, not only to detect significant predictors of HRQoL when
SF-36 is used, but also to analyze and interpret the effect of several explanatory variables on
HRQoL Arostegui et al. (2007). The comparison of this regression method based on the beta-
binomial distribution with other commonly used modelling approaches in the same context (such
as probit and multiple linear regression) showed that the beta-binomial distribution was a sat-
isfactory approach to account for over-dispersion Arostegui et al. (2012). However, there are
two different ways of implementing a regression model based on the beta-binomial distribution
in the literature. Firstly, a regression approach based on the use of a logistic link function in
the probability parameter of a beta-binomial distribution (BB logistic linkForcina and Franconi
(1988)). In this setting, estimation is done via maximum likelihood and iterative re-weighted
least squares in a Generalized Linear Model (GLM) fashion. On the other hand, the Hierarchical
Generalized Linear Model (HGLMLee and Nelder (1996)) as a generic method of performing
Generalized Linear Mixed Models (GLMMs) with non-normal random effects, which allows the
inclusion of beta distributed random effects in the linear predictor of the probability parameter
of a binomial distribution.
There are some references in the literature that compare the maximum likelihood estimation
approach, which the BB logistic link is based on, and the HGLM approach for estimating
parameters of the beta-binomial distribution, concluding that both methodologies are valid and
equivalent to fit beta-binomial distribution to some data if some second order approximations
are used in HGLM (Lee et al., 2007; Lee and Lee., 2012). However, although it has been stated
that the beta-binomial regression is a good option to analyze HRQoL data, none comparison
between these two different approaches has been addressed from a practical point of view in
a regression context where the interest lies in the estimation and interpretation of covariate
effects.
The objective of this work is to show that the different beta-binomial regression approaches
lead to contradictory results, both in regression parameters estimation and statistical significance
tests, and to provide the best option to analyze HRQoL data from the SF-36 Health Survey. In
fact, the motivation of this paper was the application of both approaches to real HRQoL data in
patients with stable Chronic Obstructive Pulmonary Disease (COPD) which yielded to different
estimates of the regression coefficients misleading the interpretation of the covariate effects in
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some circumstances. A simulation study was performed to check the different results provided
by both approaches under several controlled scenarios.
The rest of the paper is organized as follows. Section 2 presents a description of both
methodological approaches to perform a beta-binomial regression analysis in depth, together
with the widely used mixed effects logistic regression model. The application of both beta-
binomial based methodologies to real data is presented in Section 3, starting with a description
of the COPD study, continuing with the description and recoding of the SF-36 Health Survey
and finishing with the comparison of the results obtained after applying both methodologies.
Section 4 is focused in the simulation study that provides comparisons of all approaches in
controlled scenarios. Finally, in Section 5 we provide a brief discussion of the results obtained,
as well as some general conclusions and recommendations.
2 Alternative approaches for fitting beta-binomial regres-
sion
In this Section, we introduce the beta-binomial distribution and the notation we will follow
through the rest of the paper.
The beta-binomial distribution consists of a finite sum of Bernoulli dependent variables whose
probability parameter is random and follows a beta distribution. Assume that we have yj a set
of variables, j = 1, . . . ,m with m ∈ N, that conditioned on a random variable u, are independent
and follow a Bernoulli distribution with parameter u. On the other hand, the random variable
u, which we will denote the probability variable, follows a beta distribution with parameters α1
and α2. Namely,
yj |u ∼ Ber(u) and u ∼ Beta(α1, α2)
with, E[u] = ψ and Var[u] = ψ(1− ψ)φ/(1 + φ), where ψ = α1/(α1 + α2) and φ = 1/(α1 + α2).
Consequently, the marginal moments of first and second order of the variables are
E[yj ] = ψ and Var[yj ] = ψ(1− ψ),
and, ρ, the intraclass correlation is
ρ = Corr[yj , yk] =
φ
1 + φ
, j, k = 1, . . . ,m, where j 6= k, (1)
which determinates the parameter φ as the correlation parameter.





which follows a new distribution that is called beta-binomial distribution, and it is defined as
follows. The variable y follows a beta-binomial distribution if
y|u ∼ Bin(m,u) and u ∼ Beta(α1, α2). (2)
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2.1 Beta-binomial logistic regression
First, we consider the beta-binomial distribution of maximum number of scores m as a given
distribution of a set of response variables yi, i = 1, . . . , n. If we perform a reparameterization
proposed by Arostegui et al. Arostegui et al. (2007) in the beta-binomial model parameters
considering α1i = pi/φ and α2i = (1− pi)/φ, we have
E[yi] = mpi and Var[yi] = mpi(1− pi)
[




Hence, given equation (4), we can interpret the beta-binomial distribution as a binomial distri-
bution with some over-dispersion structure which is given by the intraclass correlation through
the summed Bernoulli observations. Therefore, similarly to the binomial case, pi is interpreted
as the probability of success in each Bernoulli observation of individual i. Notice that when
φ = 0, the model corresponds with the binomial case.
If we use the Gamma function property, Γ(x + 1) = xΓ(x) for all x ∈ R and Γ(0) = 1, we
get a new expression of the beta-binomial density function in equation (3), which is easier to
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where p = (p1, . . . , pn). Using this reparameterization of the beta-binomial distribution param-
eters, we have considered pi as the probability of success in each Bernoulli observation of each
individual, which allows us to link it with some given covariates by a linear predictor choosing
an appropriate link function. For regression models, Forcina et al. Forcina and Franconi (1988)
assumed that the probability parameter pi is connected to a vector of regression parameters
by means of a logit link function model, so they formulated the following relationship between
the probability parameter of the beta-binomial distribution of each individual and some given






where β is a (t + 1) × 1 vector of regression parameters and x′i, i = 1, . . . , n where n is the
number of observations, is the ith row of a full rank design matrix X composed by the given
covariates. By the relationship in equation (6) we obtain the following linear predictor,
ηi = g(pi) = log(pi/(1− pi)) = x′iβ. (7)
Therefore, replacing equation (6) on equation (5) , we can obtain the maximum likelihood
estimators of the regression parameters and dispersion parameter φ by means of an iterative
method based on the maximum likelihood approach to perform estimations and inference in the
parameters β and φ Forcina and Franconi (1988) . We will denote this model as BBlogit.
2.2 Hierarchical GLM approach
The generalized linear mixed models (GLMMs) (McCulloch and Searle, 2001), where the linear
predictor of a GLM (McCullagh and Nelder, 1989) is allowed to have, in addition to the usual
fixed effects, one or more gaussian random effects, is a very widely used methodology in different
frameworks. Although the normal distribution is convenient for specifying correlations among
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random effects, the use of other distributions for the random effects greatly enriches these
class models. Lee and Nelder Lee and Nelder (1996) extended GLMMs to hierarchical GLMs
(HGLMs), in which the distribution of random components is extended to conjugates of arbitrary
distributions from the GLM family.
The HGLMs are defined as, on the one hand, conditional on some given random components
u, the response variable y follows a GLM family, satisfying that
E[y|u] = µ and Var[y|u] = λV (µ)
and the linear predictor takes the form
η = g(µ) = Xβ + Zv,
where v = v(u), the scale, are the random effects and β are the fixed effects. On the other hand,
the random components u follow a distribution conjugate to a GLM family of distributions with
parameter φ.
We have seen in the beginning of Section 2 that, the beta-binomial model consists of a
conditioned response following a binomial distribution and some given random components u
following a beta distribution. Due to the fact that the beta distribution is conjugate to the
binomial GLM, we can consider the beta-binomial model as a special case of the HGLM family,
where
yi|ui ∼ Bin(m, pi) and ui ∼ Beta(α1, α2)
and pi is connected to ui by a linear predictor.
When we construct a HGLM we must choose v(·) the scale on which the random effects
occur linearly in the linear predictor, that is called weak canonical scale. This weak canonical
scale allows the model to maintain invariance of inference with respect to equivalent approaches
(Lee et al., 2006). Consequently, the linear predictor of the beta-binomial HGLM is
ηi = logit(pi) = x
′
iβ + vi, (8)
where x′i is the ith row of a full rank design matrix X composed by the given covariates, β are
the fixed effects and vi = logit(ui) is the random effect attributed to individual i, i = 1, . . . , n.
Constraints must be specified in either the random or fixed part of the model to maintain
the structure of the model. Lee and Nelder 2001 proposed to impose constraints in the random
part of the model, fixing the expectation of the random components u equal to value that the
scale transforms to zero. Namely, in the beta-binomial HGLM they imposed,
E[ui] = 1/2. (9)
Consequently, they defined the distribution of the random components u beta with parameters
1/α, α > 0,
ui ∼ Beta(1/α, 1/α), (10)
which fixes the previously defined beta distribution parameters ψ = 1/2 and φ = α/2.
In HGLM models, especially in the binomial beta HGLM, the computation of the marginal
likelihood is not straightforward, and moreover, it is totally uninformative about the random ef-
fects v. Consequently, Lee and Nelder Lee and Nelder (1996) proposed the so-called H-likelihood
as an approach to perform inference in HGLMs. The H-likelihood is defined by
h = h(y, v|β, φ) = log f(y|v;β) + log f(v;φ), (11)
where the first term is the conditioned log-likelihood of the response, the binomial density
function, and the second term is the log-likelihood corresponding to the random effects in the
linear predictor, the beta density function through the logit transformation.
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For inference in HGLMs three likelihoods are available, the H-likelihood and two adjusted
profile likelihoods, namely the marginal likelihood L, that eliminates nuisance random effects
v from h by integration, and the restricted likelihood, that eliminates nuisance fixed effects β
from L by conditioning on the maximum likelihood estimates of β. In principle we should use
the H-likelihood h for inference about v, the marginal-likelihood L for β, and the restricted
likelihood for the dispersion parameters (Lee et al., 2006).
2.3 Mixed effects logistic regression model
The mixed effects logistic regression model is a special case of the GLMMs, which have been
briefly introduced in the beginning of Section 2.2. First of all, we have to clarify that this
methodology is not based on the beta-binomial distribution. Consequently, due to the nature of
the paper, we have not included it in the real application section to avoid confusion to the readers.
However, simulations based on this approach have been performed and included in Section 4, as
it has been previously mentioned, the GLMM is a very widely used methodology even in HRQoL
framework. That way we can perform a full simulation study, not only concluding which beta-
binomial based approach is more appropriate for analyzing HRQoL, but also comparing them
with a commonly used methodology. For the sake of clarity, we will explain briefly in this section
what the mixed effect logistic regression consists of.
In the special case of the mixed effects logistic regression model, we assume that the responses
yi, i = 1, . . . , n, given some gaussian distributed random effects u, are conditionally independent
and follow a binomial distribution. Namely,
y|u ∼ Bin(m, pi) u ∼ N (0, D).
For analyzing the HRQoL, due to the variability that exists between different individuals, we
are going to assume that each individual is connected with a component of the random effects u.
Consequently, we are going to assume that the number of random effects is equal to the number
of individuals, that there is no correlation between the individuals and that the variance remains
constant within individuals. Namely, the variance-covariance matrix of the random effects is
D = σ2uIn.
The model defines a linear predictor ηi by assuming the following relationship between some
given covariates X1, . . . , Xt and the probability parameter of each conditioned response variable
yi,
ηi = g(pi) = x
′
iβ + ui, i = 1, . . . , n,
where g(·) is the logistic link function defined in equation (7), β is a (t+ 1)× 1 vector of fixed
regression parameters, x′i is the ith row of a full rank design matrix X composed by the given
covariates and ui is the random effect connected with ith individual.
The basis of the likelihood approximation in GLMM is the extended likelihood that includes
the random effects, plus the heuristics provided by the normal mixed models,
logL(β, σu, u) = logfy|u(y|u) + logfu(u)
where fy|u(y|u) is the conditional density function of the responses, in the mixed effects logistic
regression model the binomial density function, and fu(u) is the gaussian density function of the
random effects. Schall Schall (1991) provided an easy algorithm for performing the estimation
based on the extended likelihood approach and Breslow and Clayton Breslow and Clayton (1993)
presented applications that support its practical viability.
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3 Application to real data: COPD Study
3.1 Description of the study
Chronic Obstructive Pulmonary Disease is a very common chronic disease around the world.
Some well-designed studies have found a measured prevalence of COPD in Europe between 4%
and 10% of adults and it is expected to increase over the next years Halbert et al. (2003); Buist
et al. (2008). According to estimates of the World Health Organization (WHO), by 2020 it
shall become the third most frequent cause of death, following coronary and cerebrovascular
diseases Murray and López (1997). Moreover, patients with COPD generally have a substantial
worsening in their quality of life Esteban et al. (2009).
Researchers of the Respiratory Service at Hospital Galdakao in Spain designed the COPD
Study, a longitudinal study whose main goal was to measure the health status and evolution of
patients being treated for COPD. Patients were recruited at five outpatient respiratory clinics
affiliated with the hospital and consecutively included in the study for one year, starting at
January 2003. Patients were eligible for the study if they had been diagnosed with COPD for
at least six months and they had been receiving medical care at one of the hospital respiratory
outpatient facilities for at least six months. Their COPD had to be stable for six weeks before
enrolment. Patients were followed for up to five years. One of the aims of the study was to
measure the effect clinical and socio-demographic variables have on the HRQoL for patients with
stable COPD. In order to do that, data were selected from the patients’ first visit to the COPD
study, including a sample of 543 patients. A set of selected variables recoded in the study and
included as covariates in the models were socio-demographic variables such as gender and age,
together with forced expiratory volume in one second in percentile (FEV1%), body mass index
(BMI), dyspnea (measured with the modified scale of the Medical Research Council Mahler
et al. (2009)), the 6-minute walking testsAmerican Thoracic Society (2002) and presence of
anxiety and depression measured by the Hospital Anxiety and Depression scale (HADZigmond
and Snaith (1983)) among others. A socio-demographic and clinical summary of the exploratory
variables is presented in Table 1.
[Table 1 about here.]
3.2 Description of the SF-36 Health Survey
The SF-36 Health Survey was developed within the Medical Outcomes Study (Ware et al., 1993).
It measures generic HRQoL concepts and it provides an objective way to measure HRQoL from
the patients point of view by scoring standardized responses to standardized questions. The
validity and reliability of this instrument has been broadly tested (Stansfeld et al., 1997). The
SF-36 questionnaire has 36 items, with different answer options. It was constructed to represent
eight health dimensions, which are physical functioning (PF), role physical (RP), body pain (BP),
general health (GH), vitality (VT), social functioning (SF), role emotional (RE) and mental
health (MH). Each item is assigned to a unique health dimension. Each of the eight multi-item
dimensions contains two to ten items. The first four dimensions are mainly physical, whereas
the last four measure mental aspects of HRQoL. The standardized scoring system is thoroughly
described by the original authors (Ware et al., 1993). Briefly, each score was calculated with
an algorithm based on the original items assigned to this dimension. For each dimension, the
answers to the items were first recoded and then added in a weighted sum fashion. The resulting
raw scores were then transformed to standardized scale scores from 0 to 100, where a higher
score indicates a better health status.
Consequently, the SF-36 Health Survey generates a profile of HRQoL outcomes on eight
health dimensions. Additionally, the SF-36 includes an item related to health transition, which
is not used in the scoring of the eight health dimensions. The authors of the SF-36 Health
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Survey also provide normative scores for each health dimension. Each SF-36 score was first
standardized using the mean and standard deviations obtained from the general population and
then transformed to a norm-based (mean=50, standard deviation = 10) scoring (SF-36 Health
Survey, 1993). Two summary measures, one physical and one mental, can be created from
the eight main domains. These two summary scores were generated using the physical and
mental factor score coefficients from the general population and they were also transformed to
norm-based scoring (Ware et al., 1994). However, we have used neither norm-based scores nor
summary scores in this work.
The SF-36 Health Survey was rated in 2002 by the British Medical Journal (Garratt et al.,
2002) as the most frequently used patient reported outcome of generic health in the scientific
publications. In this work, generic HRQoL was measured using version 1.2 of the SF-36 Health
Survey, which corresponds to the version 1.4 of the Spanish version.
In order to provide a better understanding of the construction of the SF-36 Health Survey
dimensions and COPD data, we show in Table 4 the number of items related to each dimension
and the number of possible values each dimension can obtain, together with the mean and stan-
dard deviation of the original standardized SF-36 dimensions in the COPD data. In addition,
we provide in Appendix A Figure 8 where the distribution of the original standardized SF-36
dimensions in COPD data is shown. In Figure 8 the different shapes of the original standardized
SF-36 scores can be appreciated. Moreover, in Appendix A, Table 12 shows the mean and the
standard deviation of the SF-36 original standardized scores stratified by categorical covariates
of interest.
[Table 2 about here.]
3.3 Recoding of the SF-36 Health Survey scores to a binomial form
Within this section, we will briefly describe the process of analyzing HRQoL data from the SF-36
Health Survey using the beta-binomial regression approach. It includes the proposal, validation,
comparison to other methods of analysis and the recoding approach necessary in order to fit
the beta-binomial model. All the process has been thoroughly described previously. What we
present here is only a summary that could help readers to contextualize the results we show in
the present work.
The beta-binomial distribution was proposed in 2007 to fit the SF-36 Health Survey scores
(Arostegui et al., 2007). The proposal was mainly motivated because of the ordinal feature that
many of the HRQoL scales exhibit. They showed that the beta-binomial regression was a good
option to detect significant predictors of HRQoL and they also provided a nice interpretation
of the effect of explanatory variables on HRQoL when SF-36 is used. The authors also com-
pare results using multiple linear regression (MLR) and beta-binomial regression for real and
simulated data, showing that performance of the beta-binomial approach was better or similar
than the MLR approach in all the HRQoL dimensions of the SF-36. Comparison of MLR and
beta-binomial regression approaches was performed based on distributional assumptions. The
paper closed recommending the analysis of all the HRQoL scores of the SF-36 with the same
method, consequently, the authors recommended to use the beta-binomial regression.
A posterior and more general publication of the same authors (Arostegui et al., 2012) pre-
sented eight methods of analysis of patient reported outcomes, such as HRQoL, under different
assumptions that lead to different interpretations of the results. The methods were: MLR, with
least square and bootstrap estimations, tobit regression, ordinal logistic and probit regressions,
beta-binomial regression, binomial-logit-normal regression (BLNR) and coarsening. All methods
were applied to scores obtained from two of the health dimensions of the SF36 Health Survey.
The authors showed that the beta-binomial regression approach renders satisfactory results in
a broad number of situations, with a very convenient clinical interpretation of the results.
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Finally, recoding of the scores to a binomial form is necessary in order to fit the beta-binomial
distribution to the SF-36 Health Survey scores. The same authors proposed and evaluated a
method of recoding continuous and bounded scores, such as HRQoL scores, to a binomial form
(Arostegui et al., 2013). The method was mainly based on the possible number of values each
dimension can obtain, which, as it has been explained in Section 3.1 and showed in Table 4,
comes from the number of items related with the construction of each dimension. Indeed, the
methodology transforms the sorted scale of possible values of each dimension score to a ordinal
scale from 0 to m, i.e. to a binomial form scale. The real interval [0,100], which is the scale
of the standardized original scores, is divided in some subintervals, and then, each subinterval
is linked to the value that corresponds in the order of the 0 − m scale, where m + 1 is the
number of intervals. Consequently, score values within each subinterval are recoded with the
value the subinterval was linked in the 0 −m scale. The way the subintervals are constructed
is the main contribution of Arostegui et al. (2013)Arostegui et al. (2013) and the subdivision
of the 0− 100 scale for each dimension is available in the Appendix of the mentioned work. We
present in Table 5 the recoding process, step by step, for the dimensions that we will analyze
in Section 3.6. Table 5 shows the possible values of the raw and standardized scores, as well
as the subinterval division of the standardized original scores and the final recoded scores for
physical functioning, mental health and role emotional dimensions. The authors evaluated and
validated the proposed method of recoding with the scores provided by the SF-36 Health Survey.
They showed that the recoding has a natural interpretation, not only for ordinal scores, but
also for questionnaires with many dimensions and different profiles, where a common method
of analysis is desired, such as the SF-36. Briefly, let Y denote the original standardized score
observed in [0, 100] and Y ∗ the recoded ordinal score, from 0 to m, where Y ∗ ∼ Bin(m, p). Thus,
Y ∗ could be interpreted as grouped data for a dichotomous outcome that represents the number
of successes in m binomial trials and p represents the probability of success in each trial. In the
HRQoL context, Y ∗ is interpreted as the number of ”points” that an individual has and p as
the probability of obtaining one point more.
[Table 3 about here.]
3.4 Description of the SF-36 Health Survey
The SF-36 Health Survey was developed within the Medical Outcomes Study (Ware et al., 1993).
It measures generic HRQoL concepts and it provides an objective way to measure HRQoL from
the patients point of view by scoring standardized responses to standardized questions. The
validity and reliability of this instrument has been broadly tested (Stansfeld et al., 1997). The
SF-36 questionnaire has 36 items, with different answer options. It was constructed to represent
eight health dimensions, which are physical functioning (PF), role physical (RP), body pain (BP),
general health (GH), vitality (VT), social functioning (SF), role emotional (RE) and mental
health (MH). Each item is assigned to a unique health dimension. Each of the eight multi-item
dimensions contains two to ten items. The first four dimensions are mainly physical, whereas
the last four measure mental aspects of HRQoL. The standardized scoring system is thoroughly
described by the original authors (Ware et al., 1993). Briefly, each score was calculated with
an algorithm based on the original items assigned to this dimension. For each dimension, the
answers to the items were first recoded and then added in a weighted sum fashion. The resulting
raw scores were then transformed to standardized scale scores from 0 to 100, where a higher
score indicates a better health status.
Consequently, the SF-36 Health Survey generates a profile of HRQoL outcomes on eight
health dimensions. Additionally, the SF-36 includes an item related to health transition, which
is not used in the scoring of the eight health dimensions. The authors of the SF-36 Health
Survey also provide normative scores for each health dimension. Each SF-36 score was first
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standardized using the mean and standard deviations obtained from the general population and
then transformed to a norm-based (mean=50, standard deviation = 10) scoring (SF-36 Health
Survey, 1993). Two summary measures, one physical and one mental, can be created from
the eight main domains. These two summary scores were generated using the physical and
mental factor score coefficients from the general population and they were also transformed to
norm-based scoring (Ware et al., 1994). However, we have used neither norm-based scores nor
summary scores in this work.
The SF-36 Health Survey was rated in 2002 by the British Medical Journal (Garratt et al.,
2002) as the most frequently used patient reported outcome of generic health in the scientific
publications. In this work, generic HRQoL was measured using version 1.2 of the SF-36 Health
Survey, which corresponds to the version 1.4 of the Spanish version.
In order to provide a better understanding of the construction of the SF-36 Health Survey
dimensions and COPD data, we show in Table 4 the number of items related to each dimension
and the number of possible values each dimension can obtain, together with the mean and stan-
dard deviation of the original standardized SF-36 dimensions in the COPD data. In addition,
we provide in Appendix A Figure 8 where the distribution of the original standardized SF-36
dimensions in COPD data is shown. In Figure 8 the different shapes of the original standardized
SF-36 scores can be appreciated. Moreover, in Appendix A, Table 12 shows the mean and the
standard deviation of the SF-36 original standardized scores stratified by categorical covariates
of interest.
[Table 4 about here.]
3.5 Recoding of the SF-36 Health Survey scores to a binomial form
Within this section, we will briefly describe the process of analyzing HRQoL data from the SF-36
Health Survey using the beta-binomial regression approach. It includes the proposal, validation,
comparison to other methods of analysis and the recoding approach necessary in order to fit
the beta-binomial model. All the process has been thoroughly described previously. What we
present here is only a summary that could help readers to contextualize the results we show in
the present work.
The beta-binomial distribution was proposed in 2007 to fit the SF-36 Health Survey scores
(Arostegui et al., 2007). The proposal was mainly motivated because of the ordinal feature that
many of the HRQoL scales exhibit. They showed that the beta-binomial regression was a good
option to detect significant predictors of HRQoL and they also provided a nice interpretation
of the effect of explanatory variables on HRQoL when SF-36 is used. The authors also com-
pare results using multiple linear regression (MLR) and beta-binomial regression for real and
simulated data, showing that performance of the beta-binomial approach was better or similar
than the MLR approach in all the HRQoL dimensions of the SF-36. Comparison of MLR and
beta-binomial regression approaches was performed based on distributional assumptions. The
paper closed recommending the analysis of all the HRQoL scores of the SF-36 with the same
method, consequently, the authors recommended to use the beta-binomial regression.
A posterior and more general publication of the same authors (Arostegui et al., 2012) pre-
sented eight methods of analysis of patient reported outcomes, such as HRQoL, under different
assumptions that lead to different interpretations of the results. The methods were: MLR, with
least square and bootstrap estimations, tobit regression, ordinal logistic and probit regressions,
beta-binomial regression, binomial-logit-normal regression (BLNR) and coarsening. All methods
were applied to scores obtained from two of the health dimensions of the SF36 Health Survey.
The authors showed that the beta-binomial regression approach renders satisfactory results in
a broad number of situations, with a very convenient clinical interpretation of the results.
Finally, recoding of the scores to a binomial form is necessary in order to fit the beta-binomial
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distribution to the SF-36 Health Survey scores. The same authors proposed and evaluated a
method of recoding continuous and bounded scores, such as HRQoL scores, to a binomial form
(Arostegui et al., 2013). The method was mainly based on the possible number of values each
dimension can obtain, which, as it has been explained in Section 3.1 and showed in Table 4,
comes from the number of items related with the construction of each dimension. Indeed, the
methodology transforms the sorted scale of possible values of each dimension score to a ordinal
scale from 0 to m, i.e. to a binomial form scale. The real interval [0,100], which is the scale
of the standardized original scores, is divided in some subintervals, and then, each subinterval
is linked to the value that corresponds in the order of the 0 − m scale, where m + 1 is the
number of intervals. Consequently, score values within each subinterval are recoded with the
value the subinterval was linked in the 0 −m scale. The way the subintervals are constructed
is the main contribution of Arostegui et al. (2013)Arostegui et al. (2013) and the subdivision
of the 0− 100 scale for each dimension is available in the Appendix of the mentioned work. We
present in Table 5 the recoding process, step by step, for the dimensions that we will analyze
in Section 3.6. Table 5 shows the possible values of the raw and standardized scores, as well
as the subinterval division of the standardized original scores and the final recoded scores for
physical functioning, mental health and role emotional dimensions. The authors evaluated and
validated the proposed method of recoding with the scores provided by the SF-36 Health Survey.
They showed that the recoding has a natural interpretation, not only for ordinal scores, but
also for questionnaires with many dimensions and different profiles, where a common method
of analysis is desired, such as the SF-36. Briefly, let Y denote the original standardized score
observed in [0, 100] and Y ∗ the recoded ordinal score, from 0 to m, where Y ∗ ∼ Bin(m, p). Thus,
Y ∗ could be interpreted as grouped data for a dichotomous outcome that represents the number
of successes in m binomial trials and p represents the probability of success in each trial. In the
HRQoL context, Y ∗ is interpreted as the number of ”points” that an individual has and p as
the probability of obtaining one point more.
[Table 5 about here.]
Then, we will show the results obtained after applying the recoding to the SF-36 sores from
the COPD Study data. Figure 1 shows the distribution of the eight recoded HRQoL dimensions
in patients with COPD, together with the fit by the binomial and beta-binomial distributions.
Similar shape can be observed for the original scores (Figure 8) and the recoded scores (Figure
1) although represented in different scales.
[Figure 1 about here.]
Figure 1 illustrates that the distributions of the recoded SF-36 dimensions are, generally,
very skewed, accumulating values at the boundaries. As it can be seen the binomial distribution
offers a poor fit in most recoded dimensions (e.g. role physical, body pain, social functioning,
role emotional and mental health). Figure 1 also shows that the dimensions have different shapes
(e.g.: bell-shaped, U or J-shaped), due to the fact that in some dimensions people tend to answer
more or less extreme than in others. Consequently, there is an individual within variability in
each dimension, that as it can be appreciated, the beta-binomial distribution is able to fit.
Figure 2 shows in a descriptive way the distribution of the eight HRQoL dimensions provided
by the SF-36 of patients with COPD though different categorical variables, such as gender,
dyspnea, anxiety and depression. It allows the descriptive analysis of the influence of each
categorical characteristic in HRQoL of patients. Each axis of the radar chart corresponds to
a recoded SF-36 dimension. The scales have been standardized to the interval defined by the
length of the axis and divided into three cut points (25%, 50% and 75%) for a better visualization
of the mean values. In Figure 2b we can appreciate the influence of the dyspnea in the eight
HRQoL dimensions, where lower levels of dyspnea are associated to higher HRQoL in all the
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dimensions. However, it can be shown that the mean effect of different dyspnea levels is not
equal in all the dimensions, as the effects in physical functioning dimension is higher than in
body pain, differentiating category effect between physical and mental dimensions. Figure 2a
also shows that the mean perception of HRQoL is better in males than in females in all the
dimension, being the mental dimensions where the difference was higher. On the other hand,
Figures 2c-2d show that, as expected, an anxiety or depression status worsens in average the
HRQoL of COPD patients in all the dimensions, the anxiety specially in the role emotional
dimension and the depression in the vitality.
[Figure 2 about here.]
3.6 Modeling Results
Both approaches presented in Section 2, namely the BBlogit and the hglm, were applied to
data from the COPD Study. The eight dimensions of the SF-36 Health Survey were the re-
sponse variables and clinical and socio-demographic variables listed before were considered as
independent variables. Independent models were performed for each of the health dimension
of the SF-36 and exclusively data from the first visit to the outpatient clinic was considered.
For variables selection, we retained in the model those covariates whose influence in HRQoL
was statistically significant (p < 0.05) in at least one of the models. For simplicity, clarity and
brevity of exposition, we only show results for three of the eight health dimensions of the SF-36.
The selected three dimensions (physical functioning, mental health and role emotional) illustrate
different shapes of the distribution and a wide range of maximum number of scores (m), from
4 to 20.
In terms of statistical packages and software we have implemented the beta-binomial logistic
link approach in the R package HRQoL available at https://github.com/josunajera/HRQoL.
This package unifies different analysis approaches for HRQoL data from SF-36 Health Survey
and provides useful tools (such as specific quality of life radar charts). For the HGLM approach
we used the R package hglm Rönnergard et al. (2010).
Results obtained from the beta-binomial regression analysis performed with the COPD study
sample are provided in Tables 6-8. Estimates of the regression coefficients, their standard
deviations and test of significance associated to the BBlogit and the hglm modelling approaches
for the selected three health dimensions of the SF-36 Health Survey are displayed. We also show
the estimates of the dispersion parameter of each model, α for hglm from equation (10), and φ
for BBlogit from equation (1), in logarithmic scale and its significance test p-value.
[Table 6 about here.]
[Table 7 about here.]
[Table 8 about here.]
Real data application leads to several conclusions and interpretations. As regards the in-
terpretation of the fixed part regression coefficients β in both models is equivalent to the log
odds-ratio in a binomial logistic regression model. For instance, the coefficient of depression
in the physical functioning model for the BBlogit approach is -0.544, which means that based
on this model the presence of depression increases by 1/exp(-0.544)=1.72 the odds of having
a smaller physical functioning score. In term of the interpretation based on the original SF-36
score, with a range from 0 to 100, it means that the presence of depression increases by 1.72 the
odds of having 5 points less in the physical functioning domain. However, the most important
issue we address in this work is that both methodologies lead to contradictory conclusions in
terms of estimation and significance in some of the dimensions of the HRQoL provided by the
SF-36. For instance, as shown in Table 6 in physical functioning dimension both methodologies
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provided very similar results. However, in mental health (Table 7) and role emotional (Table 8)
the results were different leading to different interpretations of the covariate effects. In mental
health dimension the estimates of the coefficients were not very different, although they were not
as similar as in physical functioning dimension, but interpretation problems occurred in terms
of parameters significance. While the p-value corresponding to mild dyspnea in hglm was 0.134,
leading that there was no difference between mild and no dyspnea, in BBlogit approach the
effect was statistically significant reaching a p-value equal to 0.037. For role emotional dimen-
sion results were more contradictory, both the coefficient estimates and significances were very
different. For example, on the one hand, the estimate of the coefficient corresponding to anxiety
was -6.145 in hglm and -1.649 in BBlogit, being both statistically significant in the model. On
the other hand, the p-value corresponding to the estimate of moderate dyspnea was statistically
significant in BBlogit (<0.001), but not in hglm (0.434).
As shown in Section 2, due to the differences in constraint assumptions in both approaches
and the non linear transformation of the mean response, it is expected to reach different regres-
sion parameter estimates. The BBlogit approach parameter estimation has a population-average
interpretation while in hglm the interpretation is subject-specific, however the interpretation of
the fixed part regression coefficients β in both models is equivalent to the log odds-ratio in
a binomial logistic regression model. Consequently, the differences seem to be larger than we
have previously expected comparing population-average and subject-specific models. Real data
analysis also shows that those differences change through different shapes of the response vari-
able. Moreover, Tables 6-8 show that standard errors of the estimates are also quite different
leading to different parameter significance, and, consequently, contradictory results about the
effect of the covariates in the HRQoL of the patients with COPD. In Table 8 it is shown that
the anxiety is the unique statistically significant effect on the role emotional in hglm model,
however, the estimated parameter variance is larger than 4, which makes us think that the
estimates are over-inflated, leading to an incorrect model. Figure 3 shows the distribution of
the modelled three HRQoL dimensions and the fit by the hglm model. It can be appreciated
the subject-specific effect of the hglm model, in which the estimation is not focused on the mean
and reaches almost all the score points in the analyzed three dimensions. Figure 3 also shows
that although the estimates and variances of the parameters by hglm approach were confusing,
the fit to the data is not so bad, specially in role emotional dimension, where the fit corresponds
with the distribution of the dimension.
[Figure 3 about here.]
In general, it seems that when the value of the dispersion parameter increases, differences
between both methodologies in terms of parameter estimation and significance become greater.
The application of the two methodologies in real COPD data showed the need of the comparison
of the two models that previously one might assume that will give more similar results, at least
in terms of parameter significance. The need of a deeper analysis of the methodologies to
understand why and when differences occur and to provide the best methodology in terms of
covariate interpretation has been revealed by the real application. We believe that differences
in the results depend on the dispersion parameter. Therefore, we focus on the comparison of
the two approaches in the next section performing a complete simulation study dividing the
analysis in scenarios depending on the value of the dispersion parameter.
4 Simulation study
4.1 Simulation scenarios
In this Section we set different scenarios in order to compare different methodologies to model
HRQoL outcome data. Given the 8 health dimensions provided by the SF-36, we consider three
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groups of possible maximum scores, m, i.e.: few (4 and 3), standard (8, 9 and 10) and large
(19 and 20) Arostegui et al. (2013) (as shown in Figure 1 for COPD data). Consequently,
the simulation study has been also divided in three scenarios considering a maximum score
of 4, 10 and 20. Finally, we have generated 500 random realizations of 100 observations of a
dependent variable y assuming a beta-binomial distribution with fixed probability and dispersion
parameters.
In order to understand the behaviour of the methodologies in the HRQoL framework, we
are going to focus the simulation exercise on a regression approach with a single continuous
covariate. The probability parameter has been calculated as shown in equation (6) for a fixed
value of β0 and β1 equal to 1 and −0.3 respectively, and a fixed covariate simulated assuming a
normal distribution with mean 3 and standard deviation 2.
The value of the dispersion parameter φ defines different scenarios (the shape of the beta
distribution), as for a fixed probability parameter the shape of the distribution changes consid-
erably for different values of φ. Values greater than 0.5 provides U-shaped distributions, values
lower than 0.5 bell-shaped and a value equal to 0.5 flat-shaped. Figure 4 illustrates possible
scenarios showing how the shape of the beta-binomial distribution changes for a fixed proba-
bility parameter equal to 0.5 considering the values φ = 2 (Figure 4b), φ = 0.5 (Figure 4c)
and φ = 0.01 (Figure 4d) for the dispersion parameter. If there is no over-dispersion, φ = 0,
it corresponds to the ordinary binomial distribution (Figure 4a). Hence, when the value of
the dispersion parameter becomes greater the distribution is far from the mean value and the
observations are accumulated at both extremes.
[Figure 4 about here.]
We implemented three methodologies in the simulation study (i) HGLM, (ii) beta-binomial
regression with logistic link and (iii) mixed effects logistic regression model. The three method-
ologies have been deeply explained in Section 2.
4.2 Software implementation
The simulation process have been developed using different libraries in R (see Appendix B for
details). The HGLM approach models have been performed using hglm library, which imple-
ments the estimation algorithm for hierarchical generalized linear models (Rönnergard et al.,
2010). The rest of the models have been implemented using a library called HRQoL that has
been developed by the authors. The function that performs the logistic regression based on a
beta-binomial distribution is called BBreg() and the input is specified in a similar manner as
for the standard glm() function in R. The remaining model in the simulation study, the GLMM,
has been also performed with the so called HRQoL package by the BIMreg() function.
4.3 Results
Figures 5-7 show the box plots of the estimated regression parameters in the 500 simulations for
the three methods of estimation: (i) HGLM (hglm), (ii) beta-binomial regression with logit link
(BBlogit) and (iii) mixed-effects logistic regression (glmm). In order to compare the performance
of the methods, Tables 9-11 include the mean, the variance and the expected mean square errors
(EMS) of the estimated regression coefficients in each methodology. Tables 9-11 also show the
percentage the real value of βi is included in the 95% confidence interval of each simulation
estimate (PCI) and the percentage the simulated covariate effect is statistically significant in
each model (PCSS).
[Table 9 about here.]
[Table 10 about here.]
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[Table 11 about here.]
[Figure 5 about here.]
[Figure 6 about here.]
[Figure 7 about here.]
The simulation study shows that results of the three methodologies differ for different values
of the dispersion parameter and different maximum scores as occurred in the COPD analysis.
Generally, results provided by the hglm approach are more different to the real ones when the
maximum number of scores and the dispersion parameter increase. In this situations, the re-
gression parameter estimates have more bias than the other approaches due to the constraint
assumption it assumes, which does not allow for any conclusions about the adequacy of the
methodology. However, as the dispersion parameter increases variance of the estimates becomes
larger, increasing the uncertainty of the parameter estimates. Moreover, due to the large vari-
ability of the estimates, the significance tests of covariate effect fail, reaching in same cases a
PCSS of 22.6%, which is very low. Consequently, when the dispersion parameter is large enough,
the hglm approach is not able to capture the effect of the covariate adequately. Consequently,
patients’ and disease’s characteristics that influence the HRQoL dimensions are not going to be
detected correctly by hglm approach.
On the other hand, the BBlogit approach gets more stable results in terms of the variance
of the estimates and significance test than the hglm in all the simulated scenarios. Moreover
the obtained estimates have less bias than both hglm and glmm methodologies. Furthermore,
although when the dispersion parameter is large enough, in U-shaped scenario (Table 11), the
variance of the estimates is not too large, but specially, this methodology continues capturing
the effect of the covariate in the outcome variable correctly, reaching in the worst case a PCSS
value equal to 71.4%.
Finally, the results provided by glmm approach also lead to several conclusions. Firstly, in
the bell-shaped scenario (Table 9), as expected by the model assumption, the results provided
by glmm approach, which unlike the other methodologies it does not depend on the beta-
binomial distribution, get similar results to the hglm and BBlogit. However, as the dispersion
parameter increases, model assumption begins to fail, as the random effects are not gaussian, and
consequently, results get more unstable, increasing the variance of the estimates (Tables 10-11).
Although there are enough arguments, as explained before, to conclude that glmm approach is
not adequate to model HRQoL data, it should be emphasized that the PCSS is almost as good
as in BBlogit approach. Consequently, although the estimates and variances of the regression
parameter are not adequate, this methodology measures the statistically significant effect of the
covariate correctly.
5 Discussion
We have illustrated that the use of two different approaches for the beta-binomial regression
analysis may lead to different interpretations and statistical significances of the regression coeffi-
cients. On the one hand, apparently, results from hglm approach lead to an incorrect estimation
of the β coefficients, however we must take into account the structure of the model. By defining
random effects models we must impose constraints either on the fixed effects or in the random
effects to maintain invariance between different modelling approaches. In hglm beta-binomial
regression constraints are imposed in the random components as it was shown in equation (9),
assuming that they have expectation equal to 1/2. The linear predictor shown in equation (8) is
composed by the inclusion of random components with a logit transformation, which does not
maintain the linearity property of the expectation operator, leading to a linear predictor with
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some random effects that have no zero mean. The expectation of the random effects becomes
greater as the dispersion parameter becomes larger, and as the linear predictor must be correctly
estimated (as shown in Figure 3), differences between real and estimated β’s increase. On the
other hand, when random components are quite dispersed, a little variation in their distribution
causes a big impact on the transformation through the logit link function, changing the mean of
the random effects considerably. Hence, similar models can have different regression parameter
estimates as we have shown in the simulation study, where the variance of the estimates in
U-shaped scenario was very large. Furthermore, the impact that the prediction of the random
effects has in the regression parameter estimates is quite big, which enlarges the uncertainty
of regression parameters estimation, increasing the standard deviation of the estimates β̂ and
leading to erroneous significance tests. Consequently, although the hglm is an adequate model,
as shown in Figure 3, to fit HRQoL, it is no valid to interpret covariate effects.
From a practical point of view, researchers working on HRQoL must be provided with a
valid method of analysis for this kind of data. In some cases, the interest is focused on looking
for an adequate fit to the HRQoL data, but other studies are focused on the effect of several
covariates on HRQoL in a regression fashion. Our results showed that when the goal of the study
is to detect and interpret the effect of explanatory variables in HRQoL the method of analysis
must be cautiously selected. Therefore, we recommend the use of the BBlogit approach to
perform beta-binomial regression of HRQoL data and covariate effect analysis on HRQoL data.
Moreover, the HRQoL package in R provides the researchers the framework to perform BBlogit
analysis for HRQoL data measured with the SF-36 Health Survey as a whole process, including
the recoding of the original SF-36 scores, the descriptive analysis, the fit to the beta-binomial
distribution and the beta-binomial regression.
Finally, we have evaluated two different approaches to perform beta-binomial regression of
HRQoL as response variable and presented the results obtained for three specific dimensions of
the SF-36 health questionnaire in stable COPD patients. Alternative dimensions of the SF-36,
different HRQoL questionnaires or other populations may have different characteristics, and
therefore, methods may perform in a different way. However, many other HRQoL data and, in
general, patient-reported outcomes share many characteristics that make them suitable for the
methodological approaches presented here.
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Appendix A
We include in this Appendix some descriptive statistics of the original standardized scores of
the SF-36 in order to show the original data and its distribution. We considered Figure 8 and
Table 12 as supplementary material, which are not necessary for the correct understanding of
the applied methodology, but still helps the reader for an easier comprehension of the modeling
proposal.
[Figure 8 about here.]
[Table 12 about here.]
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Appendix B
We include a short code of the simulation study of the flat-shaped scenario for a maximum
number of score equal to 4 in R.
# Load the r equ i r ed R−packages
require ( hglm )
require (HRQoL)
beta <− c (1 ,−0.3) # Define the r e g r e s s i on c o e f f i c i e n t s
phi <− 0 .5 # Define the d i s p e r s i on parameter ( Flat−shaped )
nSim <− 500 # Number o f s imu la t i on s
nObs <− 100 # Number o f o b s e r va t i on s in each s imu la t i on
nTr ia l <− 4
set . seed (1 )
x <− rnorm(nObs , 3 , 2 ) # The cova r i a t e
rm( l i s t=” . Random . seed ” , env i r=globalenv ( ) ) # Remove the s e t . seed ()
X <− cbind (1 , x ) # The des i gn matrix o f the r e g r e s s i on c o e f f i c i e n t s
id <− seq (1 , nObs , 1 ) # The random components
p <− 1/(1+exp(−(X%∗%beta ) ) ) # The p r o b a b i l i t y parameter f o r the g iven
parameters and cova r i a t e
for ( i in 1 : nSim ) {
y <− rBB(nObs , nTria l , p , phi ) # Simulate the response v a r i a b l e
dat <− data . frame (cbind (y , x , id ) ) # Create the data frame
dat$ id <− as . factor ( dat$ id ) # Random components as f a c t o r s
# The 3 approaches
hglm <− hglm ( f i x e d=y/nTr ia l˜x , random = ˜ 1 | id , weights=rep ( nTria l , nObs
) , family = binomial ( l ink=l o g i t ) , rand . family = Beta ( l ink=l o g i t ) ,
f ix . d i sp = 1) # The hglm model
BBLogit <− BBreg ( y˜x , n=nTrial , data=dat ) # The BBlogi t model
glmm <− BIMreg ( y˜x , random=c ( ” id ” ) ,n=nTria l , data=dat ) # The glmm model
# The r e g r e s s i on c o e f f i c i e n t s
coef . hglm <− cbind ( coef . hglm , hglm$ f i x e f )
coef . BBlogit <− cbind ( coef . BBlogit , BBlogit$coef )
coef . glmm <− cbind ( coef .glm , glmm$coef f ic ients )
# The standard e r ro r s o f the e s t ima t i on s
se . hglm <− cbind ( se . hglm , hglm$SeFe )
se . BBlogit <− cbind ( se . BBlogit , sqrt (diag ( BBlogit$vcov ) ) )
se . glmm <− cbind ( se . glmm , sqrt (diag (glmm$coef . vcov ) ) )
# The var iance parameters o f the random e f f e c t s
hglm . lambda <− c ( hglm . lambda , hglm$varRanef )
BBlogit . phi <− c ( BBlogit . phi , BBlogit$phi . c o e f f i c i e n t )
glmm . sigma <− c (glmm . sigma , glmm$random . se )
# The random e f f e c t s
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hglm . rand <− cbind ( hglm . rand , hglm$ r ane f )
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Figure 1: Histogram and fit with binomial and beta-binomial distributions of the recoded HRQoL
















































































































































(d) Distribution of the HRQoL by the
depression
Figure 2: Distribution of HRQoL in COPD patients through some categorical variables. Numbers
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Figure 3: Observed distribution and fitted distribution by the hglm approach of HRQoL scores.
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Figure 4: Different scenarios based on parameter φ.
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Figure 5: Box plots of the slope estimates in the simulation study for bell-shaped scenario (φ =
0.01). Simulations performed for n = 100 individuals and R = 500 replicates.
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Figure 6: Box plots of the slope estimates in the simulation study for flat-shaped scenario (φ = 0.5).
Simulations performed for n = 100 individuals and R = 500 replicates.
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Figure 7: Box plots of the slope estimates in the simulation study for U-shaped scenario (φ = 2).











































































































































































































































Figure 8: Distribution of the original standardized scores of the eight SF-36 dimensions in COPD
data. Frequencies are shown at the top of each bar.
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Table 1: Descriptive analysis of the socio-demographic and clinical variables. The total number of
individuals is n = 543.
















Walking Test 408.89 (92.43)
SD: Standard Deviation; BMI: Body Mass Index; FEV1%: Forced Expiratory Volume in one second in percentile.
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Table 2: Descriptive analysis of the original standardized scores of the eight SF-36 dimensions in
COPD data.
Dimension Mean SD No. of items No. of possible values
Physical functioning 57.762 24.382 10 21
Role physical 65.608 38.916 4 5
Body pain 71.087 29.259 2 27
General health 44.672 21.934 5 39
Vitality 59.355 24.957 4 21
Social functioning 81.534 24.460 2 9
Role emotional 80.172 35.905 3 4
Mental health 73.422 22.918 5 26
SD: Standard Deviation.
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Table 3: Recoding methodology for role emotional, mental health and physical functioning dimen-
sions.
Role emotional Mental health
Raw Stdr. Inter. Recoded Raw Stdr. Inter. Recoded
3 0 [0, 16.67] 0 5 0 [0,2] 0
4 33.3 (16.67, 50] 1 6 4 (2,10] 1
5 66.7 (50, 83.33] 2 7 8
6 100 (83.33, 100] 3 8 12 (10,18] 2
9 16
10 20 (18, 26] 3
Physical functioning 11 24
Raw Stadr. Inter. Recoded 12 28 (26,34] 4
10 0 [0, 2.5] 0 13 32
11 5 (2.5, 7.5] 1 14 36 (34,42] 5
12 10 (7.5, 12.5] 2 15 40
13 15 (12.5, 17.5] 3 16 44 (42,50] 6
14 20 (17.5, 22.5] 4 17 48
15 25 (22.5, 27.5] 5 18 52 (50,58] 7
16 30 (27.5, 32.5] 6 19 56
17 35 (32.5, 37.5] 7 20 60 (58,66] 8
18 40 (37.5, 42.5] 8 21 64
19 45 (42.5, 47.5] 9 22 68 (66,74] 9
20 50 (47.5, 52.5] 10 23 72
21 55 (52.5, 57.5] 11 24 76 (74,82] 10
22 60 (57.5, 62.5] 12 25 80
23 65 (62.5, 67.5] 13 26 84 (82,90] 11
24 70 (67.5, 72.5] 14 27 88
25 75 (72.5, 77.5] 15 28 92 (90,98] 12
26 80 (77.5, 82.5] 16 29 96
27 85 (82.5, 87.5] 17 30 100 (98,100] 13
28 90 (87.5, 92.5] 18
29 95 (92.5, 97.5] 19
30 100 (97.5, 100] 20
Raw: Raw scores; Stdr.: Standardized original scores; Inter.: The subinterval division of the 0− 100 scale; Recoded:
Recoding of the values. The decomposition in raw and original standardized scores of the HRQoL dimensions is
developed in Ware et al. (1993) (Ware et al., 1993), while the subinterval division and recoding process is explicitly
explained in Arostegui et al. (2013) (Arostegui et al., 2013).
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Table 4: Descriptive analysis of the original standardized scores of the eight SF-36 dimensions in
COPD data.
Dimension Mean SD No. of items No. of possible values
Physical functioning 57.762 24.382 10 21
Role physical 65.608 38.916 4 5
Body pain 71.087 29.259 2 27
General health 44.672 21.934 5 39
Vitality 59.355 24.957 4 21
Social functioning 81.534 24.460 2 9
Role emotional 80.172 35.905 3 4
Mental health 73.422 22.918 5 26
SD: Standard Deviation.
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Table 5: Recoding methodology for role emotional, mental health and physical functioning dimen-
sions.
Role emotional Mental health
Raw Stdr. Inter. Recoded Raw Stdr. Inter. Recoded
3 0 [0, 16.67] 0 5 0 [0,2] 0
4 33.3 (16.67, 50] 1 6 4 (2,10] 1
5 66.7 (50, 83.33] 2 7 8
6 100 (83.33, 100] 3 8 12 (10,18] 2
9 16
10 20 (18, 26] 3
Physical functioning 11 24
Raw Stadr. Inter. Recoded 12 28 (26,34] 4
10 0 [0, 2.5] 0 13 32
11 5 (2.5, 7.5] 1 14 36 (34,42] 5
12 10 (7.5, 12.5] 2 15 40
13 15 (12.5, 17.5] 3 16 44 (42,50] 6
14 20 (17.5, 22.5] 4 17 48
15 25 (22.5, 27.5] 5 18 52 (50,58] 7
16 30 (27.5, 32.5] 6 19 56
17 35 (32.5, 37.5] 7 20 60 (58,66] 8
18 40 (37.5, 42.5] 8 21 64
19 45 (42.5, 47.5] 9 22 68 (66,74] 9
20 50 (47.5, 52.5] 10 23 72
21 55 (52.5, 57.5] 11 24 76 (74,82] 10
22 60 (57.5, 62.5] 12 25 80
23 65 (62.5, 67.5] 13 26 84 (82,90] 11
24 70 (67.5, 72.5] 14 27 88
25 75 (72.5, 77.5] 15 28 92 (90,98] 12
26 80 (77.5, 82.5] 16 29 96
27 85 (82.5, 87.5] 17 30 100 (98,100] 13
28 90 (87.5, 92.5] 18
29 95 (92.5, 97.5] 19
30 100 (97.5, 100] 20
Raw: Raw scores; Stdr.: Standardized original scores; Inter.: The subinterval division of the 0− 100 scale; Recoded:
Recoding of the values. The decomposition in raw and original standardized scores of the HRQoL dimensions is
developed in Ware et al. (1993) (Ware et al., 1993), while the subinterval division and recoding process is explicitly
explained in Arostegui et al. (2013) (Arostegui et al., 2013).
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Table 6: Effect of explanatory variables in physical functioning dimension measured by beta-
binomial regression and estimated by both approaches.
hglm BBlogit
Physical functioning β̂ SD(β̂) p-value β̂ SD(β̂) p-value
Dyspnea
Mild -0.616 0.111 <0.001 -0.580 0.112 <0.001
Moderate -1.339 0.122 <0.001 -1.281 0.120 <0.001
Severe -2.317 0.178 <0.001 -2.207 0.176 <0.001
Depression
Yes -0.541 0.139 <0.001 -0.544 0.130 <0.001
Anxiety
Yes -0.416 0.096 <0.001 -0.404 0.090 <0.001
Sex
Female 0.469 0.167 0.005 0.461 0.155 0.003
FEV1% 0.007 0.003 0.011 0.006 0.002 0.012
BMI -0.019 0.007 0.011 -0.018 0.007 0.009
Age 0.013 0.004 0.002 0.012 0.004 0.002
Walking Test 0.004 10−4 <0.001 0.004 10−4 <0.001
log(α) -2.656 0.084 <0.001 − − −
log(φ) − − − -2.826 0.115 <0.001
SD: Standard Deviation; BMI: Body Mass Index; FEV1%: Forced Expiratory Volume in one second in percentile.
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Table 7: Effect of explanatory variables in mental health dimension measured by beta-binomial
regression and estimated by both approaches.
hglm BBlogit
Mental health β̂ SD(β̂) p-value β̂ SD(β̂) p-value
Dyspnea
Mild -0.353 0.234 0.134∗ -0.294 0.141 0.037
Moderate -0.853 0.246 <0.001 -0.704 0.145 <0.001
Severe -1.132 0.320 <0.001 -0.961 0.181 <0.001
Anxiety
Yes -1.480 0.204 <0.001 -1.290 0.108 <0.001
Depression
Yes -0.966 0.298 0.002 -0.853 0.157 <0.001
log(α) -0.7647 0.069 <0.001 − − −
log(φ) − − − -2.263 0.115 <0.001
SD: Standard Deviation. Symbol ∗ stands for regression coefficients that were not statistically significant.
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Table 8: Effect of explanatory variables in role emotional dimension measured by beta-binomial
regression and estimated by both approaches.
hglm BBlogit
Role emotional β̂ SD(β̂) p-value β̂ SD(β̂) p-value
Anxiety
Yes -6.145 2.062 0.003 -1.649 0.226 <0.001
Dyspnea
Mild -2.600 5.229 0.619∗ -0.614 0.418 0.142∗
Moderate -3.981 5.080 0.434∗ -1.379 0.413 <0.001
Severe -5.603 5.496 0.309∗ -2.048 0.467 <0.001
log(α) 2.735 0.095 <0.001 − − −
log(φ) − − − 0.668 0.150 <0.001
SD: Standard Deviation. Symbol ∗ stands for regression coefficients that were not statistically significant.
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Table 9: Results of the simulation study for the bell-shaped distribution (φ = 0.01) for n = 100
individuals and R = 500 replicates.
True value β0 = 1 β1 = −0.3
Method Mean(SD) EMS PCI Mean(SD) EMS PCI PCSS
m = 4 hglm 1.024 (0.245) 0.060 95.8% -0.309 (0.067) 0.004 97.4% 100%
BBlogit 1.007 (0.228) 0.052 95.6% -0.304 (0.063) 0.004 97.2% 100%
glmm 1.015 (0.230) 0.053 95.8% -0.306 (0.063) 0.004 97.6% 100%
m = 10 hglm 1.018 (0.173) 0.030 96.0% -0.305 (0.048) 0.002 95.8% 100%
BBlogit 1.001 (0.169) 0.028 95.6% -0.299 (0.047) 0.002 96.0% 100%
glmm 1.016 (0.170) 0.029 95.6% -0.304 (0.047) 0.002 95.8% 100%
m = 20 hglm 1.030 (0.140) 0.020 94.8% -0.308 (0.038) 0.001 95.2% 100%
BBlogit 1.004 (0.136) 0.019 95.4% -0.304 (0.037) 0.001 96.0% 100%
glmm 1.027 (0.140) 0.020 94.8% -0.308 (0.038) 0.001 95.0% 100%
SD: Standard Deviation; EMS: Expected Mean Square errors; PCI: Percentage the real value is included in the 95%
Confidence Interval of each simulation estimate; PCSS: Percentage the covariate effect is statistically significant.
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Table 10: Results of the simulation study for the flat-shaped distribution (φ = 0.5) for n = 100
individuals and R = 500 replicates.
True value β0 = 1 β1 = −0.3
Method Mean(SD) EMS PCI Mean(SD) EMS PCI PCSS
m = 4 hglm 1.284 (0.476) 0.307 96.4% -0.384 (0.132) 0.024 95.6% 91.8%
BBlogit 0.960 (0.280) 0.080 97.0% -0.289 (0.078) 0.006 96.0% 92.6%
glmm 1.100 (0.321) 0.113 96.6% -0.330 (0.088) 0.009 96.4% 93.4%
m = 10 hglm 1.420 (0.514) 0.440 91.2% -0.425 (0.138) 0.034 89.0% 96.0%
BBlogit 0.953 (0.258) 0.069 95.8% -0.287 (0.071) 0.005 95.0% 98.8%
glmm 1.230 (0.331) 0.162 91.2% -0.331 (0.091) 0.013 88.4% 98.6%
m = 20 hglm 1.574 (0.528) 0.610 86.8% -0.468 (0.139) 0.048 83.2% 94.0%
BBlogit 0.985 (0.252) 0.064 95.8% -0.296 (0.064) 0.005 96.6% 99.2%
glmm 1.370 (0.350) 0.259 81.0% -0.411 (0.094) 0.021 80.0% 99.2%
SD: Standard Deviation; EMS: Expected Mean Square errors; PCI: Percentage the real value is included in the 95%
Confidence Interval of each simulation estimate; PCSS: Percentage the covariate effect is statistically significant.
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Table 11: Results of the simulation study for the U-shaped distribution (φ = 2) for n = 100
individuals and R = 500 replicates.
True value β0 = 1 β1 = −0.3
Method Mean(SD) EMS PCI Mean(SD) EMS PCI PCSS
m = 4 hglm 1.809 (0.988) 1.631 97.4% -0.559 (0.287) 0.150 92.6% 62.8%
BBlogit 0.776 (0.294) 0.137 94.4% -0.244 (0.086) 0.010 94.0% 71.4%
glmm 1.105 (0.412) 0.181 99.0% -0.347 (0.120) 0.016 97.6% 72.2%
m = 10 hglm 2.630 (1.648) 5.394 92.2% -0.801 (0.467) 0.470 85.4% 39.6%
BBlogit 0.777 (0.307) 0.144 92.8% -0.244 (0.091) 0.011 91.2% 76.2%
glmm 1.375 (0.528) 0.420 96.2% -0.431 (0.156) 0.041 91.2% 75.2%
m = 20 hglm 3.210 (2.250) 9.946 86.2% -0.951 (0.570) 0.749 81.6% 22.6%
BBlogit 0.801 (0.313) 0.137 91.6% -0.249 (0.086) 0.010 93.0% 82.0%
glmm 1.594 (0.614) 0.730 88.4% -0.498 (0.170) 0.068 84.4% 80.8%
SD: Standard Deviation; EMS: Expected Mean Square errors; PCI: Percentage the real value is included in the 95%
Confidence Interval of each simulation estimate; PCSS: Percentage the covariate effect is statistically significant.
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Table 12: Mean and standard deviation, in parenthesis, of the original standardized scores of the
eight SF-36 dimensions stratified by categorical covariates of interest.
Covariates n PF RP BP GH VT SF RE MH
Sex:
Male 522 57.87 66.14 71.49 44.92 60.00 82.28 81.03 74.04
(24.58) (38.65) (29.10) (22.01) (24.71) (23.61) (35.04) (22.42)
Female 21 55.00 52.38 61.00 38.48 43.33 64.29 58.78 58.09
(18.97) (43.95) (32.01) (19.32) (26.33) (36.93) (49.33) (29.71)
Dyspnea
No 69 81.23 91.30 78.09 60.52 80.21 92.03 91.79 83.30
(18.08) (22.62) (30.17) (19.41) (19.40) (18.56) (24.52) (18.86)
Mild 264 67.29 75.19 73.45 49.95 66.46 87.22 86.99 78.70
(17.57) (35.15) (27.79) (20.92) (21.33) (19.37) (30.54) (19.95)
Moderate 166 43.67 49.65 66.57 34.17 45.48 73.12 71.08 65.16
(16.54) (37.99) (29.41) (18.04) (21.92) (26.64) (40.12) (24.42)
Severe 44 16.93 27.27 62.93 27.79 36.36 63.35 55.30 57.45
(11.11) (33.16) (32.36) (15.88) (19.95) (31.48) (44.28) (21.94)
Depression:
No 506 59.53 67.29 71.78 46.18 61.79 83.32 81.55 76.04
(23.69) (38.40) (29.11) (21.62) (23.61) (22.83) (34.82) (20.39)
Yes 37 33.51 42.57 61.68 23.93 26.08 57.77 61.26 37.62
(20.68) (39.03) (29.97) (14.60) (18.26) (32.72) (44.80) (25.78)
Anxiety:
No 459 60.63 69.72 73.54 47.24 63.42 85.95 85.91 79.15
(23.66) (37.24) (28.26) (21.64) (23.43) (21.01) (30.99) (18.04)
Yes 84 42.08 43.15 57.68 30.61 37.14 57.74 48.81 42.09
(22.32) (40.39) (30.59) (17.92) (21.13) (28.11) (44.04) (21.44)
n: Number of individuals, PF: Physical functioning, RP: Role physical, BP: Body pain, GH: General health, VT:
Vitality, SF: Social functioning, RE: Role emotional, MH: Mental health.
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